Analyst Reco. Enhabit, Inc.

Equities

EHAB

US29332G1022

Market Closed - Nyse Other stock markets 01:30:02 27/04/2024 am IST			5-day change	1st Jan Change
10.03 ^USD	+1.62%		-2.15%	-3.09%

08/03	UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	MT
08/03	North American Morning Briefing : Stock Futures -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	08/03	MT
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target	07/03	MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating	06/03	MT
TD Cowen Starts Enhabit With Market Perform Rating	12/12	MT
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating	11/23/11	MT
Goldman Sachs Adjusts Price Target on Enhabit to $13 From $15, Maintains Neutral Rating	17/23/17	MT
UBS Adjusts Enhabit Price Target to $9.50 From $11, Maintains Sell Rating	12/23/12	MT
Goldman Sachs Starts Enhabit at Neutral With $15 Price Target	16/23/16	MT
CJS Securities Initiates Coverage on Enhabit With Market Perform Rating, $18 Price Target	13/22/13	MT
UBS Initiates Coverage on Enhabit With Sell Rating, $12 Price Target	08/22/08	MT
Stifel Starts Enhabit at Buy With $17 Price Target	06/22/06	MT
Credit Suisse Lowers Enhabit's Price Target to $15 From $19 on Further Mix Shift, Labor Cost Pressures; Keeps Neutral Rating	04/22/04	MT
Oppenheimer Initiates Coverage on Enhabit With Perform Rating	14/22/14	MT
Jefferies Initiates Enhabit at Buy with $20 Price Target	30/22/30	MT
Credit Suisse Initiates Enhabit at Neutral with $19 Price Target, Says Mid-to-High Single-Digit Annual Organic Growth Possible Long-Term	25/22/25	MT
RBC Cuts Price Target on Encompass Health to $66 From $82, Citing Enhabit Home Health & Hospice Spinoff, Maintains Outperform Rating	24/22/24	MT
Citigroup Initiates Enhabit at Neutral With $17 Price Target	18/22/18	MT
BofA Securities Initiates Enhabit at Underperform With $16 Price Target	13/22/13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer